Cargando…
Artemether and Praziquantel: Origin, Mode of Action, Impact, and Suggested Application for Effective Control of Human Schistosomiasis
The stumbling block for the continued, single-drug use of praziquantel (PZQ) against schistosomiasis is less justified by the risk of drug resistance than by the fact that this drug is inactive against juvenile parasites, which will mature and start egg production after chemotherapy. Artemisinin der...
Autores principales: | Bergquist, Robert, Elmorshedy, Hala |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306701/ https://www.ncbi.nlm.nih.gov/pubmed/30572592 http://dx.doi.org/10.3390/tropicalmed3040125 |
Ejemplares similares
-
Controlling schistosomiasis with praziquantel: How much longer without a viable alternative?
por: Bergquist, Robert, et al.
Publicado: (2017) -
Can human schistosomiasis mansoni control be sustained in high-risk transmission foci in Egypt?
por: Elmorshedy, Hala, et al.
Publicado: (2015) -
Elimination of schistosomiasis requires multifactorial diagnostics: evidence from high- and low-prevalence areas in the Nile Delta, Egypt
por: Elmorshedy, Hala, et al.
Publicado: (2020) -
Praziquantel for the treatment of schistosomiasis during human pregnancy
por: Friedman, Jennifer F, et al.
Publicado: (2018) -
Anaphylactic reaction to praziquantel following schistosomiasis treatment
por: Vasconcelos, Géssica Almeida, et al.
Publicado: (2023)